TYRA BIOSCIENCES, INC.
TYRA
20.39
+0.15
+0.74%
TYRA BIOSCIENCES, INC.
US · TYRA
#3032 by market cap
Listed 2021
20.39
+0.15
+0.74%
Live - 5344 symbols - heartbeat 198s ago
· 2026-10-07 19:54
After-hours
20.39
0.00%
- Market cap
- 1.40B
- P/E (TTM)i
- -8.53
- P/Bi
- 3.96
- EPSi
- -2.01
- Div yieldi
- 0.00%
- 52W posi
- 26%
Reader sentiment
Are you bullish or bearish on TYRA?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 11 analysts
Buy
Avg price target
47.40 +132.5%
Price target rangecurrent 20.39
Low29.00
Avg47.40
High59.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-30 | Barclays | -- | BUY | 59.00 |
| 2026-09-23 | Raymond James | -- | BUY | 50.00 |
| 2026-09-22 | CCORF | -- | BUY | 50.00 |
| 2026-09-22 | H.C. Wainwright | -- | BUY | 29.00 |
| 2026-09-22 | Oppenheimer | -- | BUY | 40.00 |
| 2026-09-11 | Wedbush | -- | BUY | 53.00 |
| 2026-09-10 | CCORF | -- | BUY | 50.00 |
| 2026-09-10 | JonesTrading | -- | BUY | 56.00 |
| 2026-09-10 | H.C. Wainwright | -- | BUY | 30.00 |
| 2026-09-10 | Barclays | -- | BUY | 59.00 |
| 2026-09-09 | William Blair | -- | BUY | -- |
| 2026-09-08 | CCORF | -- | BUY | 50.00 |
| 2026-09-08 | Piper Sandler | -- | BUY | 56.00 |
| 2026-09-08 | BofA Securities | -- | BUY | 39.00 |
| 2026-09-08 | H.C. Wainwright | -- | BUY | 45.00 |
| 2026-09-07 | JonesTrading | -- | BUY | 56.00 |
| 2026-09-04 | H.C. Wainwright | -- | BUY | 45.00 |
| 2026-08-25 | CCORF | -- | BUY | 50.00 |
| 2026-08-12 | CCORF | -- | BUY | 50.00 |
| 2026-08-11 | BofA Securities | -- | BUY | 39.00 |
| 2026-08-05 | William Blair | -- | BUY | -- |
| 2026-08-05 | Wedbush | -- | BUY | 53.00 |
| 2026-08-05 | Jefferies | -- | BUY | 42.00 |
| 2026-08-05 | H.C. Wainwright | -- | BUY | 45.00 |
| 2026-08-04 | JonesTrading | -- | BUY | 56.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Sell
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.